No consensus definition of 'success' exists in autism stem-cell trials. Published case reports describe changes in irritability, focus or social initiation in selected children, but these lack objective measurement and controls. Across the 26 registered trials outcomes range widely; some report no measurable change. 'Success-rate' figures in promotional materials are unvalidated and derive from unblinded studies. Treat any high-success claim with scepticism.
Twenty-six registered trials and 6 actively recruiting studies explore stem-cell approaches in autism, primarily small, uncontrolled observational designs. Published reports describe behavioural changes in individual cases, but lack placebo controls, randomisation, or blinded assessment. Most data come from Asia-Pacific clinics; few reach peer-reviewed journals. The theoretical rationale — that placental MSCs reduce neuroinflammation — remains unproven in human brains. No trial has demonstrated meaningful, durable change in core autism features attributable to stem cells alone.
我是候选人吗？ → · Autism Spectrum Disorder: full overview → · 自闭症谱系障碍成本 → · Cost →
由 StemCellAtlas 的编辑团队进行医学审查，与Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估